Sign Up to like & get
recommendations!
1
Published in 2019 at "Annals of Oncology"
DOI: 10.1093/annonc/mdz244.033
Abstract: Abstract Background LUR is a new agent that exerts antitumor activity through inhibition of trans-activated transcription and modulation of tumor microenvironment. Preclinical synergism/additivity in combination with IRI has been reported, thus prompting the conduct of…
read more here.
Keywords:
time employment;
full part;
iri;
pharmamar ... See more keywords